Amedisys Stock Performance

AMED Stock  USD 92.46  0.17  0.18%   
The firm shows a Beta (market volatility) of -0.19, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Amedisys are expected to decrease at a much lower rate. During the bear market, Amedisys is likely to outperform the market. Amedisys has an expected return of -0.0445%. Please make sure to confirm Amedisys potential upside, day median price, and the relationship between the total risk alpha and accumulation distribution , to decide if Amedisys performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Amedisys has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Amedisys is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more

Actual Historical Performance (%)

One Day Return
0.18
Year To Date Return
(2.64)
Ten Year Return
527.7
All Time Return
1.7 K
Last Split Factor
4:3
Last Split Date
2006-12-05
1
Amedisys Research Coverage Started at StockNews.com - MarketBeat
01/18/2024
2
Acquisition by Denise Bohnert of 5518 shares of Amedisys subject to Rule 16b-3
02/16/2024
3
Disposition of 1415 shares by Denise Bohnert of Amedisys at 93.69 subject to Rule 16b-3
02/20/2024
4
Brokerages Set Amedisys, Inc. PT at 103.22
02/26/2024
5
UnitedHealth slumps on DoJ antitrust probe and ransomware hacker reports
02/28/2024
6
Bank of Nova Scotia Acquires Shares of 285,557 Amedisys, Inc.
02/29/2024
7
Amedisys Earns Buy Rating from Analysts at StockNews.com - MarketBeat
03/06/2024
8
Hudson Bay Capital Management LP Has 15.55 Million Stock Position in Amedisys, Inc. - MarketBeat
03/13/2024
9
UPDATE 1-Oregons health authority reviewing UnitedHealths acquisition of Amedisys
03/19/2024
10
How Amedisys Stock Stands Out in a Strong Industry
03/20/2024
11
RBC raises Amedisys stock PT to 100 on AMED deal completion confidence
03/25/2024
Begin Period Cash Flow61.7 M
  

Amedisys Relative Risk vs. Return Landscape

If you would invest  9,506  in Amedisys on December 29, 2023 and sell it today you would lose (260.00) from holding Amedisys or give up 2.74% of portfolio value over 90 days. Amedisys is currently does not generate positive expected returns and assumes 0.4343% risk (volatility on return distribution) over the 90 days horizon. In different words, 3% of stocks are less volatile than Amedisys, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Amedisys is expected to under-perform the market. But the company apears to be less risky and when comparing its historical volatility, the company is 1.32 times less risky than the market. the firm trades about -0.1 of its potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.23 of returns per unit of risk over similar time horizon.

Amedisys Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Amedisys' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Amedisys, and traders can use it to determine the average amount a Amedisys' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1025

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsAMED

Estimated Market Risk

 0.43
  actual daily
3
97% of assets are more volatile

Expected Return

 -0.04
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.1
  actual daily
0
Most of other assets perform better
Based on monthly moving average Amedisys is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amedisys by adding Amedisys to a well-diversified portfolio.

Amedisys Fundamentals Growth

Amedisys Stock prices reflect investors' perceptions of the future prospects and financial health of Amedisys, and Amedisys fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Amedisys Stock performance.

About Amedisys Performance

To evaluate Amedisys Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Amedisys generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Amedisys Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Amedisys market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Amedisys's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Return On Capital Employed 0.12  0.13 
Return On Assets(0)(0)
Return On Equity(0.01)(0.01)

Things to note about Amedisys performance evaluation

Checking the ongoing alerts about Amedisys for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Amedisys help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Amedisys generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 2.24 B. Net Loss for the year was (9.75 M) with profit before overhead, payroll, taxes, and interest of 453.98 M.
Over 96.0% of the company shares are held by institutions such as insurance companies
Latest headline from investing.com: RBC raises Amedisys stock PT to 100 on AMED deal completion confidence
Evaluating Amedisys' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Amedisys' stock performance include:
  • Analyzing Amedisys' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Amedisys' stock is overvalued or undervalued compared to its peers.
  • Examining Amedisys' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Amedisys' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Amedisys' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Amedisys' stock. These opinions can provide insight into Amedisys' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Amedisys' stock performance is not an exact science, and many factors can impact Amedisys' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amedisys. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.
Note that the Amedisys information on this page should be used as a complementary analysis to other Amedisys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for Amedisys Stock analysis

When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Is Amedisys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.40)
Earnings Share
(0.30)
Revenue Per Share
68.603
Quarterly Revenue Growth
0.016
Return On Assets
0.0598
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.